Case Report: Torsade de Pointes Induced by the Third-Generation Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Osimertinib Combined With Litsea Cubeba

Torsades de Pointes (TdP) occurred in a 68-year-old female with epidermal growth factor receptor (EGFR) mutant lung cancer administered osimertinib, the third-generation EGFR tyrosine kinase inhibitor (TKI). Electrocardiogram (ECG) recorded at Tdp showed QT prolongation (QTc = 515 ms), to which a Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xia-yan, Wu, Cha-bin, Wu, Cai-xia, Lin, Li, Zhou, Yue-juan, Zhu, Yan-yan, Tian, Wei-qiang, Luo, Song-mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193968/
https://www.ncbi.nlm.nih.gov/pubmed/35711361
http://dx.doi.org/10.3389/fcvm.2022.903354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193968/
https://www.ncbi.nlm.nih.gov/pubmed/35711361
http://dx.doi.org/10.3389/fcvm.2022.903354

Ejemplares similares